NCT06700330

Brief Summary

The aim of this research is to study the etiology, the clinical picture, the management, the complications and the outcomes of necrotic pancreatitis in children. Currently, there is a significant number of errors in the early diagnosis of AP in children associated with the complexity of differential diagnosis, which leads to the untimely verification of the correct diagnosis and, consequently, to incorrect treatment tactics, which could be accompanied by an increase in the severe forms of the disease and an increase in mortality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 20, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 21, 2024

Completed
10 days until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 18, 2025

Completed
Last Updated

February 20, 2025

Status Verified

February 1, 2025

Enrollment Period

1 month

First QC Date

November 20, 2024

Last Update Submit

February 18, 2025

Conditions

Keywords

PancreatitisAcute Necrotizing PancreatitisChildren

Outcome Measures

Primary Outcomes (1)

  • the frequency of occurrence of various etiologic causes of necrotizing pancreatitis in children

    based on the study, the most common causes of necrotizing pancreatitis in children will be identified

    From enrollment to the end of treatment (2 month)

Secondary Outcomes (11)

  • The duration from the onset of the disease to the start of the treatment

    from the onset of the disease to the end of treatment (up to 20 weeks)

  • The duration of hospital stay

    from admission to hospital until the end of treatment (up to 8 weeks)

  • The length of ICU stay

    During ICU stay (up to 60 days)

  • The effect of comorbidities on the severity of the disease

    from admission to hospital until the end of treatment (up to 8 weeks)

  • Intestinal failure

    from admission to hospital until the end of treatment (up to 8 weeks)

  • +6 more secondary outcomes

Study Arms (1)

Children with necrotizing pancreatitis

children who have suffered acute pacreatitis

Other: no intervention, observational study

Interventions

Only data from the patient file.

Children with necrotizing pancreatitis

Eligibility Criteria

Age0 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky

You may qualify if:

  • Consent of the patient or legal representative
  • Age from 0-18 years
  • Moderate severe (MSAP) or severe acute pancreatitis (SAP) according to Atlanta criteria revisited in 2012
  • Acute Pancreatitis was established in the presence of at least two of three criteria according to the classification developed by the INSPPIRE group (International Study Group of Pediatric Pancreatitis: In Search for a Cure): abdominal pain corresponding to the diagnostic hypothesis; an increase in amylase and / or lipase in the blood serum by ≥3 times; imaging findings characteristic of AP: abdominal ultrasound and/or contrast-enhanced CT.

You may not qualify if:

  • mild acute pancreatitis
  • chronic pancreatitis
  • no consent from patient or legal representative

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky

Moscow, Moscow Oblast, 129110, Russia

Location

MeSH Terms

Conditions

PancreatitisPancreatitis, Acute Necrotizing

Interventions

Observation

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Officials

  • Dmitriy A Pyhteev, PhD

    Head of the Department of Pediatric Surgery

    STUDY DIRECTOR
  • Leonid M Elin

    Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 20, 2024

First Posted

November 21, 2024

Study Start

December 1, 2024

Primary Completion

January 10, 2025

Study Completion

February 18, 2025

Last Updated

February 20, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

A complete dataset can be provided upon reasoned request

Locations